Gemini Update Clinical decision support based on Bevacizumab cancer trials and pushing the limitations of advanced LLMs
Fuente:
Zenodo
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Recurso digital |
| Lingua: | inglese |
| Pubblicazione: |
Zenodo
2025
|
| Soggetti: | |
| Accesso online: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
| _version_ | 1866901709083639808 |
|---|---|
| author | Kawchak, Kevin |
| author_facet | Kawchak, Kevin |
| contents | <p>BREAKING: Exact Recall Milestone for Challenging Clinical Decision Support Task This update to the full January 27, 2025 study significantly improves on Standard 2a results regarding a reasoning Large Language Model’s ability to provide exact recall of author citations and quotations on a comprehensive input [1]. 100 Bevacizumab cancer therapy articles representing over 900K words were previously summarized into 100 reports totaling 49K words, and have now been analyzed by Google Gemini to yield a more accurate clinical decision support (CDS) study. The primarily limitation of the model was less advanced reasoning ability versus current OpenAI o1 and o3-mini models. The relevance of highly accurate quotations and citations is that clinical researchers require consistent and verifiable information along with LLM contextual awareness of clinical studies with associated speed advantages.</p> |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_14968289 |
| institution | Zenodo |
| language | eng |
| publishDate | 2025 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | Gemini Update Clinical decision support based on Bevacizumab cancer trials and pushing the limitations of advanced LLMs Kawchak, Kevin Gemini Claude LLM Clinical decision support Bevacizumab cancer trials AI <p>BREAKING: Exact Recall Milestone for Challenging Clinical Decision Support Task This update to the full January 27, 2025 study significantly improves on Standard 2a results regarding a reasoning Large Language Model’s ability to provide exact recall of author citations and quotations on a comprehensive input [1]. 100 Bevacizumab cancer therapy articles representing over 900K words were previously summarized into 100 reports totaling 49K words, and have now been analyzed by Google Gemini to yield a more accurate clinical decision support (CDS) study. The primarily limitation of the model was less advanced reasoning ability versus current OpenAI o1 and o3-mini models. The relevance of highly accurate quotations and citations is that clinical researchers require consistent and verifiable information along with LLM contextual awareness of clinical studies with associated speed advantages.</p> |
| title | Gemini Update Clinical decision support based on Bevacizumab cancer trials and pushing the limitations of advanced LLMs |
| topic | Gemini Claude LLM Clinical decision support Bevacizumab cancer trials AI |
| url | https://doi.org/10.5281/zenodo.14968289 |